Exact Mass: 493.2729
Exact Mass Matches: 493.2729
Found 500 metabolites which its exact mass value is equals to given mass value 493.2729
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Syringolin A
A syrbactin that has a (3E,9E)-2,7-dioxo-1,6-diazacyclododeca-3,9-diene skeleton that is substituted by an isopropyl group at position 5 and by a [(2S)-2-({[(1S)-1-carboxy-2-methylpropyl]carbamoyl}amino)-3-methylbutanoyl]nitrilo group at the 8-pro-S position. It is produced by the pathogenic bacterium Pseudomonas syringae pv. syringae.
Imatinib
Imatinib is a drug used to treat certain types of cancer. It is currently marketed by Novartis as Gleevec (USA) or Glivec (Europe/Australia) as its mesylate salt, imatinib mesilate (INN). It is occasionally referred to as CGP57148B or STI571 (especially in older publications). It is used in treating chronic myelogenous leukemia (CML), gastrointestinal stromal tumors (GISTs) and a number of other malignancies. It is the first member of a new class of agents that act by inhibiting particular tyrosine kinase enzymes, instead of non-specifically inhibiting rapidly dividing cells. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EA - Bcr-abl tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor COVID info from Guide to PHARMACOLOGY, clinicaltrial, clinicaltrials, clinical trial, clinical trials C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164037 - PDGFR-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163999 - cKIT-targeting Agent C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159198 - c-KIT Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C155700 - BCR-ABL Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Cytochalasin Npho
Cytochalasin Npho is a mycotoxin from Phomopsis sp Mycotoxin from Phomopsis species
4-[[2-Methyl-2-[4-[5-(trifluoromethyl)pyridin-2-yl]piperazin-1-yl]propanoyl]amino]adamantane-1-carboxamide
Imatinib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EA - Bcr-abl tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor COVID info from Guide to PHARMACOLOGY, clinicaltrial, clinicaltrials, clinical trial, clinical trials C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164037 - PDGFR-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163999 - cKIT-targeting Agent C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159198 - c-KIT Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C155700 - BCR-ABL Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; INTERNAL_ID 2742 INTERNAL_ID 2742; CONFIDENCE standard compound CONFIDENCE standard compound; INTERNAL_ID 8521 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3633
C28H35N3O5_(1R,5R,7S,12R)-12-Hydroxy-4,4,4,4,12,14-hexamethyl-4H,13H-spiro[9,14-diazatetracyclo[5.5.2.0~1,9~.0~3,7~]tetradecane-5,8-[1,4]dioxepino[2,3-g]indole]-9,13(10H)-dione
Ala Glu Phe Lys
Ala Glu Lys Phe
Ala Phe Glu Lys
Ala Phe Lys Glu
Ala Phe Arg Thr
Ala Phe Thr Arg
Ala Ile Lys Tyr
Ala Ile Gln Tyr
Ala Ile Tyr Lys
Ala Ile Tyr Gln
Ala Lys Glu Phe
Ala Lys Phe Glu
Ala Lys Ile Tyr
Ala Lys Leu Tyr
Ala Lys Tyr Ile
Ala Lys Tyr Leu
Ala Leu Lys Tyr
Ala Leu Gln Tyr
Ala Leu Tyr Lys
Ala Leu Tyr Gln
Ala Gln Ile Tyr
Ala Gln Leu Tyr
Ala Gln Tyr Ile
Ala Gln Tyr Leu
Ala Arg Phe Thr
Ala Arg Thr Phe
Ala Thr Phe Arg
Ala Thr Arg Phe
Ala Tyr Ile Lys
Ala Tyr Ile Gln
Ala Tyr Lys Ile
Ala Tyr Lys Leu
Ala Tyr Leu Lys
Ala Tyr Leu Gln
Ala Tyr Gln Ile
Ala Tyr Gln Leu
Glu Ala Phe Lys
Glu Ala Lys Phe
Glu Phe Ala Lys
Glu Phe Lys Ala
Glu Lys Ala Phe
Glu Lys Phe Ala
Phe Ala Glu Lys
Phe Ala Lys Glu
Phe Ala Arg Thr
Phe Ala Thr Arg
Phe Glu Ala Lys
Phe Glu Lys Ala
Phe Ile Lys Ser
Phe Ile Asn Thr
Phe Ile Gln Ser
Phe Ile Ser Lys
Phe Ile Ser Gln
Phe Ile Thr Asn
Phe Lys Ala Glu
Phe Lys Glu Ala
Phe Lys Ile Ser
Phe Lys Leu Ser
Phe Lys Ser Ile
Phe Lys Ser Leu
Phe Lys Thr Val
Phe Lys Val Thr
Phe Leu Lys Ser
Phe Leu Asn Thr
Phe Leu Gln Ser
Phe Leu Ser Lys
Phe Leu Ser Gln
Phe Leu Thr Asn
Phe Asn Ile Thr
Phe Asn Leu Thr
Phe Asn Thr Ile
Phe Asn Thr Leu
Phe Gln Ile Ser
Phe Gln Leu Ser
Phe Gln Ser Ile
Phe Gln Ser Leu
Phe Gln Thr Val
Phe Gln Val Thr
Phe Arg Ala Thr
Phe Arg Thr Ala
Phe Ser Ile Lys
Phe Ser Ile Gln
Phe Ser Lys Ile
Phe Ser Lys Leu
Phe Ser Leu Lys
Phe Ser Leu Gln
Phe Ser Gln Ile
Phe Ser Gln Leu
Phe Thr Ala Arg
Phe Thr Ile Asn
Phe Thr Lys Val
Phe Thr Leu Asn
Phe Thr Asn Leu
Phe Thr Gln Val
Phe Thr Arg Ala
Phe Thr Val Lys
Phe Thr Val Gln
Phe Val Lys Thr
Phe Val Gln Thr
Phe Val Thr Lys
Phe Val Thr Gln
Gly Arg Val Tyr
Gly Arg Tyr Val
Gly Val Arg Tyr
Gly Val Tyr Arg
Gly Tyr Arg Val
Gly Tyr Val Arg
His Ile Pro Gln
His Ile Gln Pro
His Leu Pro Gln
His Leu Gln Pro
His Pro Ile Gln
His Pro Leu Gln
His Pro Gln Ile
His Pro Gln Leu
His Gln Ile Pro
His Gln Leu Pro
His Gln Pro Ile
His Gln Pro Leu
Ile Ala Lys Tyr
Ile Ala Gln Tyr
Ile Ala Tyr Lys
Ile Ala Tyr Gln
Ile Phe Lys Ser
Ile Phe Asn Thr
Ile Phe Gln Ser
Ile Phe Ser Lys
Ile Phe Ser Gln
Ile Phe Thr Asn
Ile His Pro Gln
Ile His Gln Pro
Ile Lys Ala Tyr
Ile Lys Phe Ser
Ile Lys Ser Phe
Ile Lys Tyr Ala
Ile Asn Phe Thr
Ile Asn Thr Phe
Ile Pro His Gln
Ile Pro Gln His
Ile Gln Ala Tyr
Ile Gln Phe Ser
Ile Gln His Pro
Ile Gln Pro His
Ile Gln Ser Phe
Ile Gln Tyr Ala
Ile Ser Phe Lys
Ile Ser Phe Gln
Ile Ser Lys Phe
Ile Ser Gln Phe
Ile Thr Phe Asn
Ile Tyr Ala Lys
Ile Tyr Ala Gln
Ile Tyr Lys Ala
Lys Ala Ile Tyr
Lys Ala Leu Tyr
Lys Ala Tyr Ile
Lys Ala Tyr Leu
Lys Phe Ile Ser
Lys Phe Leu Ser
Lys Phe Ser Ile
Lys Phe Ser Leu
Lys Phe Thr Val
Lys Phe Val Thr
Lys Ile Ala Tyr
Lys Ile Phe Ser
Lys Ile Ser Phe
Lys Ile Tyr Ala
Lys Leu Ala Tyr
Lys Leu Phe Ser
Lys Leu Ser Phe
Lys Leu Tyr Ala
Lys Ser Phe Ile
Lys Ser Phe Leu
Lys Ser Ile Phe
Lys Ser Leu Phe
Lys Thr Phe Val
Lys Thr Val Phe
Lys Val Phe Thr
Lys Val Thr Phe
Lys Tyr Ala Ile
Lys Tyr Ala Leu
Lys Tyr Ile Ala
Lys Tyr Leu Ala
Leu Ala Lys Tyr
Leu Ala Tyr Lys
Leu Phe Lys Ser
Leu Phe Ser Lys
Leu His Pro Gln
Leu His Gln Pro
Leu Lys Ala Tyr
Leu Lys Phe Ser
Leu Lys Ser Phe
Leu Lys Tyr Ala
Leu Pro His Gln
Leu Pro Gln His
Leu Gln His Pro
Leu Gln Pro His
Leu Ser Phe Lys
Leu Ser Lys Phe
Leu Tyr Ala Lys
Leu Tyr Lys Ala
Pro His Ile Gln
Pro His Leu Gln
Pro His Gln Ile
Pro His Gln Leu
Pro Ile His Gln
Pro Ile Gln His
Pro Leu His Gln
Pro Leu Gln His
Pro Gln His Ile
Pro Gln His Leu
Pro Gln Ile His
Pro Gln Leu His
Gln Ala Tyr Leu
Gln His Ile Pro
Gln His Leu Pro
Gln His Pro Ile
Gln His Pro Leu
Gln Ile His Pro
Gln Ile Pro His
Gln Leu His Pro
Gln Leu Pro His
Gln Pro His Ile
Gln Pro His Leu
Gln Pro Ile His
Gln Pro Leu His
Arg Ala Phe Thr
Arg Ala Thr Phe
Arg Phe Ala Thr
Arg Phe Thr Ala
Arg Gly Val Tyr
Arg Gly Tyr Val
Arg Thr Ala Phe
Arg Thr Phe Ala
Arg Val Gly Tyr
Arg Val Tyr Gly
Arg Tyr Gly Val
Arg Tyr Val Gly
Ser Phe Ile Lys
Ser Phe Lys Ile
Ser Phe Lys Leu
Ser Phe Leu Lys
Ser Phe Gln Ile
Ser Phe Gln Leu
Ser Ile Phe Lys
Ser Ile Phe Gln
Ser Ile Lys Phe
Ser Ile Gln Phe
Ser Lys Phe Ile
Ser Lys Phe Leu
Ser Lys Ile Phe
Ser Lys Leu Phe
Ser Lys Pro Tyr
Ser Lys Tyr Pro
Ser Leu Phe Lys
Ser Leu Phe Gln
Ser Leu Lys Phe
Ser Leu Gln Phe
Ser Pro Lys Tyr
Ser Pro Tyr Lys
Ser Gln Phe Ile
Ser Gln Phe Leu
Ser Gln Ile Phe
Ser Gln Leu Phe
Ser Tyr Lys Pro
Ser Tyr Pro Lys
Thr Ala Phe Arg
Thr Ala Arg Phe
Thr Phe Ala Arg
Thr Phe Ile Asn
Thr Phe Lys Val
Thr Phe Leu Asn
Thr Phe Asn Ile
Thr Phe Asn Leu
Thr Phe Gln Val
Thr Phe Arg Ala
Thr Phe Val Lys
Thr Phe Val Gln
Thr Ile Phe Asn
Thr Ile Asn Phe
Thr Lys Phe Val
Thr Lys Val Phe
Thr Leu Phe Asn
Thr Leu Asn Phe
Thr Asn Phe Ile
Thr Asn Phe Leu
Thr Asn Ile Phe
Thr Asn Leu Phe
Thr Gln Phe Val
Thr Gln Val Phe
Thr Arg Ala Phe
Thr Arg Phe Ala
Thr Val Phe Lys
Thr Val Phe Gln
Thr Val Lys Phe
Thr Val Gln Phe
Val Phe Lys Thr
Val Phe Gln Thr
Val Phe Thr Lys
Val Phe Thr Gln
Val Gly Arg Tyr
Val Gly Tyr Arg
Val Lys Phe Thr
Val Lys Thr Phe
Val Asn Val Tyr
Val Asn Tyr Val
Val Gln Phe Thr
Val Gln Thr Phe
Val Arg Gly Tyr
Val Arg Tyr Gly
Val Thr Phe Lys
Val Thr Phe Gln
Val Thr Lys Phe
Val Thr Gln Phe
Val Val Asn Tyr
Val Val Tyr Asn
Val Tyr Gly Arg
Val Tyr Asn Val
Val Tyr Arg Gly
Val Tyr Val Asn
Tyr Ala Ile Lys
Tyr Ala Ile Gln
Tyr Ala Lys Ile
Tyr Ala Lys Leu
Tyr Ala Leu Lys
Tyr Ala Leu Gln
Tyr Ala Gln Ile
Tyr Ala Gln Leu
Tyr Gly Arg Val
Tyr Gly Val Arg
Tyr Ile Ala Lys
Tyr Ile Ala Gln
Tyr Ile Lys Ala
Tyr Ile Gln Ala
Tyr Lys Ala Ile
Tyr Lys Ala Leu
Tyr Lys Ile Ala
Tyr Lys Leu Ala
Tyr Lys Pro Ser
Tyr Lys Ser Pro
Tyr Leu Ala Lys
Tyr Leu Ala Gln
Tyr Leu Lys Ala
Tyr Leu Gln Ala
Tyr Asn Val Val
Tyr Pro Lys Ser
Tyr Pro Ser Lys
Tyr Gln Ala Ile
Tyr Gln Ala Leu
Tyr Gln Ile Ala
Tyr Gln Leu Ala
Tyr Arg Gly Val
Tyr Arg Val Gly
Tyr Ser Lys Pro
Tyr Ser Pro Lys
Tyr Val Gly Arg
Tyr Val Asn Val
Tyr Val Arg Gly
Tyr Val Val Asn
Cytochalasin Npho
(2S,3S)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one
(2S,3S)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one
(1R,9S,10S,11S)-12-[2-(dimethylamino)acetyl]-10-(hydroxymethyl)-11-(4-methylpiperazine-1-carbonyl)-5-phenyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one
(2R,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one
(2R,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one
(2R,3S)-2-[[cyclopentylmethyl(methyl)amino]methyl]-8-[2-(3-fluorophenyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
N-[(5R,6R,9S)-8-[cyclopropyl(oxo)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
N-[(5R,6S,9R)-8-[cyclopropyl(oxo)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
methyl N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylcarbamate
1-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[4-(phenylmethyl)-1-piperidinyl]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-(2-methoxyphenyl)urea
1-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[4-(phenylmethyl)-1-piperidinyl]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-(2-methoxyphenyl)urea
methyl N-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylcarbamate
(2S,3S)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one
(2R,3R)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one
(2S,3R)-8-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one
(2R,3S)-10-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one
1-[[(4R,5R)-8-(1-cyclohexenyl)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methyl-3-propylurea
N-[(5R,6R,9R)-8-[cyclopropyl(oxo)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
N-[(5S,6S,9S)-8-[cyclopropyl(oxo)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
N-[(5S,6S,9R)-8-[cyclopropyl(oxo)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
N-[(5S,6R,9S)-8-[cyclopropyl(oxo)methyl]-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]benzamide
methyl N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylcarbamate
methyl N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylcarbamate
methyl N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylcarbamate
1-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[4-(phenylmethyl)-1-piperidinyl]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-(2-methoxyphenyl)urea
1-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[4-(phenylmethyl)-1-piperidinyl]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-(2-methoxyphenyl)urea
1-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[4-(phenylmethyl)-1-piperidinyl]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-(2-methoxyphenyl)urea
1-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[4-(phenylmethyl)-1-piperidinyl]ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-(2-methoxyphenyl)urea
(1S,9R,10R,11R)-12-[2-(dimethylamino)acetyl]-10-(hydroxymethyl)-11-(4-methylpiperazine-1-carbonyl)-5-phenyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one
methyl N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylcarbamate
methyl N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylcarbamate
(1S,6R,7R,8R)-6-Hydroxy-4,4,6,10,10,13-hexamethylspiro[10H-[1,4]dioxepino[2,3-g]indole-8,11-3,13-diazatetracyclo[5.5.2.01,9.03,7]tetradecane]-9,14-dione
[3-acetyloxy-2-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-butanoyloxypropan-2-yl] (Z)-tetradec-9-enoate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] (Z)-pentadec-9-enoate
[1-acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] (Z)-hexadec-9-enoate
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] (Z)-tridec-9-enoate
2-(3-(1-(((4E,10E)-2,9-Dioxo-12-isopropyl-1,8-diazacyclododecane-4,10-diene-3-yl)carbamoyl)-2-methylpropyl)ureido)-3-methylbutyric acid
phosphatidylethanolamine 18:1 zwitterion
A 1,2-diacyl-sn-glycero-3-phosphoethanolamine zwitterion in which the two acyl groups contain a total of 18 carbons and 1 double bond.
phosphatidylcholine 15:1
A 1,2-diacyl-sn-glycero-3-phosphocholine in which the two acyl groups contain a total of 15 carbons and 1 double bond.
PC(15:1)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
(1'r,3'r,7's,8r,12'r)-9,12'-dihydroxy-4,4,4',4',12',14'-hexamethyl-9',14'-diazaspiro[[1,4]dioxepino[2,3-g]indole-8,5'-tetracyclo[5.5.2.0¹,⁹.0³,⁷]tetradecan]-13'-one
14-ethyl-2,6-dihydroxy-4,19-dimethoxy-16-methyl-9,11-dioxa-14-azaheptacyclo[10.7.2.1²,⁵.0¹,¹³.0³,⁸.0⁸,¹².0¹⁶,²⁰]docosan-21-yl acetate
3-benzyl-1,6,12-trihydroxy-4,10,12-trimethyl-5-methylidene-3h,3ah,4h,6h,6ah,9h,10h,11h,15h-cycloundeca[d]isoindol-15-yl acetate
(3s,3ar,6s,6ar,10s,12r,15r,15ar)-3-benzyl-1,6,12-trihydroxy-4,5,10,12-tetramethyl-3h,3ah,6h,6ah,9h,10h,11h,15h-cycloundeca[d]isoindol-15-yl acetate
3beta-acetoxynorerythrosuamine
{"Ingredient_id": "HBIN008156","Ingredient_name": "3beta-acetoxynorerythrosuamine","Alias": "3\u03b2-acetoxynorerythrosuamine","Ingredient_formula": "C26H39NO8","Ingredient_Smile": "CC1C2C(CCC1=CC(=O)OCCNC)C3(CCC(C(C3C(=O)C2O)(C)C(=O)OC)OC(=O)C)C","Ingredient_weight": "493.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "25340;265","TCMSP_id": "NA","TCM_ID_id": "8175;24321","PubChem_id": "101606278","DrugBank_id": "NA"}